Video Experimental Relacionado
Updated: Jul 18, 2026
10:08
Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
Published on: August 28, 2012
Procesamiento del precursor de la proteína amiloide a derivados potencialmente amiloidogénicos
T E Golde1, S Estus, L H Younkin
1Division of Neuropathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Science (New York, N.Y.)
|February 7, 1992
Resumen
El procesamiento del precursor de la proteína beta amiloide (beta APP) difiere entre las vías secretoras y endosomal-lisosomal. El sistema endosómico-lisosomal genera derivados beta AP potencialmente amiloidogénicos, a diferencia de la vía secretora.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Biología Molecular Biología Molecular
- Biología celular Biología celular.
Sus antecedentes:
- El precursor de la proteína beta amiloide (beta APP) es una proteína clave implicada en las enfermedades neurodegenerativas.
- beta APP se procesa en varios derivados carboxilo-terminales, algunos de los cuales son potencialmente amiloidogénicos.
Objetivo del estudio:
- Para investigar si los derivados beta APP se procesan a través de la vía secretora o el sistema endosómico-lisosomal.
- Para identificar la vía específica responsable de la generación de derivados de APP beta potencialmente amiloidogénicos.
Principales métodos:
- Análisis de mutantes de deleción de beta APP para estudiar los derivados secretados y carboxilo-terminales.
- Examen de los efectos de los inhibidores del proceso endosómico-lisosómico en la formación de derivados beta APP.
Principales resultados:
- La escisión de beta APP en la vía secretora produce un derivado secretado y un fragmento no amiloidogénico.
- El procesamiento dentro del sistema endosómico-lisosomal produce un complejo conjunto de derivados carboxilo-terminales, incluidas formas potencialmente amiloidogénicas.
Conclusiones:
- El sistema endosómico-lisosomal es responsable de generar derivados carboxilo-terminales potencialmente amiloidogénicos de la beta APP.
- Comprender las vías de procesamiento de beta APP es crucial para desarrollar estrategias terapéuticas para enfermedades relacionadas.
Videos de Conceptos Relacionados
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
02:11Proteins: From Genes to Degradation
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA molecules by RNA...
Transcription is the synthesis of RNA molecules by RNA...
01:39Mitochondrial Precursor Proteins
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...
Most of the mitochondrial precursors...
01:29Protein Folding Quality Check in the RER
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
01:32Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...